Analysis Suggests Women Are More Likely To Survive Malignant Melanoma.
MedPage Today (6/7) reported that women with a malignant melanoma are "less likely to die or to have the cancer progress," according to findings presented at a medical conference. The analysis of "outcomes data from seven European clinical trials," which included more than "6,700 patients," showed that compared with men, women with localized disease had a "hazard ratio of 0.70 for death, compared with 0.81 and 0.83, respectively, for those with stage III and IV disease." Similarly, women with localized disease had a "hazard ratio for progression of 0.69, while those with stage III and IV disease had hazard ratios of 0.86 and 0.79," respectively; and women with localized and stage III disease had "hazard ratios for the time to distant metastasis of 0.69 and 0.87," respectively. The researchers suggest the "observed discrepancy has been behavior. 'Men wait too long to see their doctors, so they come in with thicker tumors and a worse prognosis.'"http://www.bobbybukamd.com/ http://www.drbobby.com/ http://www.wbderm.com/ http://www.williamsburgderm.com/
No comments:
Post a Comment
Learn Something New Today About Your Skin?